Report cover image

Voice Mood Disorder Dx Market Forecasts to 2032 – Global Analysis By Component (Solutions and Services), Deployment Mode (Cloud and On-premise), Disorder Type, Biomarker Type, Technology, Application, End User and By Geography

Published Sep 02, 2025
Length 200 Pages
SKU # SMR20346638

Description

According to Stratistics MRC, the Global Voice Mood Disorder Dx Market is accounted for $599.92 million in 2025 and is expected to reach $1519.68 million by 2032 growing at a CAGR of 14.2% during the forecast period. The Voice Mood Disorder Dx describes the growing application of AI-driven analysis and voice-based biomarkers for the diagnosis and tracking of mood disorders like bipolar disorder, anxiety, and depression. Tone, pitch, rhythm, intensity, and pauses are just a few examples of the subtle changes in speech patterns that frequently reveal underlying emotional and cognitive states that are difficult to identify with conventional clinical evaluations. By analyzing these characteristics using natural language processing (NLP) and machine learning, Voice Mood Disorder Dx systems provide a non-invasive, scalable, and real-time mental health assessment. Early detection, ongoing monitoring, and integration with telehealth platforms are all possible with this technology, which could enhance patient accessibility and individualized treatment plans.

According to a study published in Frontiers in Neurology, voice-based machine learning models have demonstrated the ability to diagnose depressive and manic mood states by analyzing 1,337 voice messages from 93 participants. The study found that specific vocal features, such as pitch, rhythm, and pauses, were indicative of mood states, suggesting the potential of voice analysis in mood disorder diagnostics.

Market Dynamics:

Driver:

Increasing mental health disorder prevalence

The prevalence of mental health issues is raising quickly throughout the world, especially mood disorders like bipolar disorder, anxiety, and depression. Women are disproportionately affected by depression, which affects over 280 million people globally, according to the World Health Organization. Accurate diagnosis and intervention may be delayed by the use of subjective evaluations and self-reports in traditional diagnostic techniques. There is an immediate need for novel, trustworthy, and scalable diagnostic tools as a result of this increasing prevalence. Moreover, a promising approach to early detection, ongoing monitoring, and better management of mental health disorders worldwide is voice-based diagnostics, which examine minute vocal changes linked to emotional states.

Restraint:

Data security and privacy issues

Voice-based diagnostics present serious privacy issues since they necessitate the gathering and examination of private health and personal information. Patients may be concerned that their vocal and emotional data may be misused, accessed without authorization, or compromised. Although regulatory frameworks such as GDPR in Europe and HIPAA in the United States enforce stringent compliance standards, regional variations pose difficulties for global implementation. Providing voice data with secure storage, encrypted transmission, and appropriate anonymization is expensive and technically challenging. Furthermore, adoption may be slowed by public mistrust of digital health platforms. Rapid market expansion may be limited if companies are unable to maintain patient trust and comply with legal requirements while balancing innovation with strict data protection measures.

Opportunity:

Extension of remote monitoring and telehealth

The quick development of telehealth offers a big chance for voice-based diagnosis of mood disorders. Integrating voice analysis tools into telemedicine platforms can enable ongoing mental health monitoring without requiring in-person visits, as patients increasingly seek out remote consultations. Clinicians can use remote monitoring to monitor subtle behavioral and emotional changes over time, allowing for early intervention and individualized treatment plans. Additionally, by lowering barriers for patients in underserved or rural areas, this integration broadens the market. The COVID-19 pandemic and other events have accelerated the demand for digital health solutions. As a result, telehealth adoption offers a favorable environment for the global deployment of scalable, voice-based mental health diagnostics.

Threat:

Strong rivalry and quick changes in technology

The market is getting more and more competitive, with established tech firms, startups, and providers of healthcare solutions fighting for market share. If current tools do not adapt to the rapid advancements in technology, they may soon become outdated. Competitors may gain market share by providing more precise, affordable, or user-friendly solutions, which would put pressure on margins and impede growth. Although it raises operating costs and risk, ongoing R&D investment is necessary to remain relevant. Due to the rapid advancement of AI, natural language processing, and digital health technologies, businesses must constantly adjust or risk falling behind more sophisticated diagnostic tools.

Covid-19 Impact:

The Voice Mood Disorder Dx market was significantly impacted by the COVID-19 pandemic, which presented both opportunities and difficulties. Globally, mental health problems increased as a result of social isolation, lockdowns, and elevated stress levels, which raised the need for early mood disorder detection and monitoring. Social distancing policies made it more difficult to conduct traditional in-person evaluations, which sped up the use of non-invasive, remote diagnostic tools like voice-based ones. AI-powered voice analysis was incorporated into telehealth platforms to facilitate early intervention, ongoing monitoring, and individualized treatment. However, the abrupt change also brought to light issues with digital literacy, infrastructure, and data privacy that businesses needed to resolve in order to continue growing.

The cloud segment is expected to be the largest during the forecast period

The cloud segment is expected to account for the largest market share during the forecast period because of their scalability, flexibility, and cheaper infrastructure costs than on-premise deployments, cloud-based solutions are recommended. Without requiring a lot of hardware at the user's location, they make it possible to collect, process, and analyze voice biomarker data in real time. Cloud platforms facilitate machine learning models and AI-driven analytics, enabling remote access and ongoing monitoring for both patients and clinicians. Furthermore, cloud solutions improve accessibility and adoption by enabling smooth integration with mobile apps and telehealth services. Centralized algorithm updates also guarantee more precise, current diagnostic capabilities, which propel the segment's market leadership.

The telehealth providers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the telehealth providers segment is predicted to witness the highest growth rate. The need for telehealth platforms that can provide voice-based mood and mental health assessments has increased dramatically due to the growing use of remote healthcare solutions, particularly in the wake of COVID-19. These providers close gaps in mental health care, especially in underserved areas, by allowing patients to obtain diagnostic services from the convenience of their homes. Moreover, the fastest-growing market segment is telehealth due to developments in AI-driven voice analysis tools that enable real-time, precise mood detection, improving early intervention and individualized treatment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by the region's substantial investment in mental health research, high adoption of digital health technologies, and sophisticated healthcare infrastructure. Leading healthcare providers, diagnostic firms, and encouraging regulatory environments all contribute to the market's expansion. Widespread adoption has also been aided by growing knowledge of mental health issues and the use of voice-based and AI-based diagnostic tools in clinical settings. Additionally, North America's leadership in the global voice mood disorder diagnostics market is cemented by robust government initiatives and the rising demand for remote and customized diagnostic solutions.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Digital diagnostic solutions are being adopted in nations like China, India, and Japan due to factors like rapid urbanization, rising internet and smartphone penetration, and increased awareness of mental health issues. The incorporation of AI-based voice analysis tools for the early detection of mood disorders and increased investments in healthcare infrastructure are also driving market expansion. Furthermore, Asia-Pacific is emerging as the region with the fastest rate of growth in the global voice mood disorder diagnostics market thanks to supportive government initiatives, the growth of telehealth, and the development of mobile health platforms.

Key players in the market

Some of the key players in Voice Mood Disorder Dx Market include Cogito Corporation, Sonde Health, Ellipsis Health Inc, Psyrin, Canary Speech Inc, Beyond Verbal, Thymia, Kintsugi, CompanionMx, LangAware, Vocalis Health, Winterlight Labs, Mindstrong Health, NeuroLex Laboratories and Aiberry Inc.

Key Developments:

In June 2025, Ellipsis Health announced it has raised $45 million in a new Series A funding round. Salesforce, Khosla Ventures and CVS Health Ventures led the round. Mitsui Global Investment, Collier, E12 and AME Cloud Ventures participated in the round. The company is also introducing Sage, an AI care manager aimed at supporting patients with physical, behavioral and social needs.

In August 2024, Sonde Health announces it has been selected by AFWERX for a SBIR Phase II contract in the amount of $1,215,606 focused on Sonde Mental Fitness to address the most pressing challenges in the Department of the Air Force (DAF).

In October 2023, Cogito announced it has secured new funding to help advance features aimed at better supporting agents in the contact center and improving customer experiences. The funding round, including repeat commitments from two major investors, validates the importance of delivering strong employee and customer experiences in today’s turbulent economic climate.

Components Covered:
• Solutions
• Services

Deployment Modes Covered:
• Cloud
• On-premise

Disorder Types Covered:
• Depression
• Bipolar Disorder
• Anxiety Disorders
• Post-Traumatic Stress Disorder (PTSD)
• Schizophrenia
• Other Disorder Types

Biomarker Types Covered:
• Frequency-based Biomarkers
• Amplitude-based Biomarkers
• Vocal Fold Dynamics-based Biomarkers
• Other Biomarker Types

Technologies Covered:
• Voice Biomarkers
• Natural Language Processing (NLP)
• Machine Learning Algorithms
• Acoustic Signal Processing

Applications Covered:
• Cognitive
• Behavioral

End Users Covered:
• Hospitals & Clinics
• Diagnostic Centers
• Telehealth Providers
• Research Institutions
• Mental Health Apps & Platforms

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

200 Pages
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Voice Mood Disorder Dx Market, By Component
5.1 Introduction
5.2 Solutions
5.3 Services
6 Global Voice Mood Disorder Dx Market, By Deployment Mode
6.1 Introduction
6.2 Cloud
6.3 On-premise
7 Global Voice Mood Disorder Dx Market, By Disorder Type
7.1 Introduction
7.2 Depression
7.3 Bipolar Disorder
7.4 Anxiety Disorders
7.5 Post-Traumatic Stress Disorder (PTSD)
7.6 Schizophrenia
7.7 Other Disorder Types
8 Global Voice Mood Disorder Dx Market, By Biomarker Type
8.1 Introduction
8.2 Frequency-based Biomarkers
8.3 Amplitude-based Biomarkers
8.4 Vocal Fold Dynamics-based Biomarkers
8.5 Other Biomarker Types
9 Global Voice Mood Disorder Dx Market, By Technology
9.1 Introduction
9.2 Voice Biomarkers
9.3 Natural Language Processing (NLP)
9.4 Machine Learning Algorithms
9.5 Acoustic Signal Processing
10 Global Voice Mood Disorder Dx Market, By Application
10.1 Introduction
10.2 Cognitive
10.3 Behavioral
11 Global Voice Mood Disorder Dx Market, By End User
11.1 Introduction
11.2 Hospitals & Clinics
11.3 Diagnostic Centers
11.4 Telehealth Providers
11.5 Research Institutions
11.6 Mental Health Apps & Platforms
12 Global Voice Mood Disorder Dx Market, By Geography
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa
13 Key Developments
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies
14 Company Profiling
14.1 Cogito Corporation
14.2 Sonde Health
14.3 Ellipsis Health Inc
14.4 Psyrin
14.5 Canary Speech Inc
14.6 Beyond Verbal
14.7 Thymia
14.8 Kintsugi
14.9 CompanionMx
14.10 LangAware
14.11 Vocalis Health
14.12 Winterlight Labs
14.13 Mindstrong Health
14.14 NeuroLex Laboratories
14.15 Aiberry Inc
List of Tables
Table 1 Global Voice Mood Disorder Dx Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Voice Mood Disorder Dx Market Outlook, By Component (2024-2032) ($MN)
Table 3 Global Voice Mood Disorder Dx Market Outlook, By Solutions (2024-2032) ($MN)
Table 4 Global Voice Mood Disorder Dx Market Outlook, By Services (2024-2032) ($MN)
Table 5 Global Voice Mood Disorder Dx Market Outlook, By Deployment Mode (2024-2032) ($MN)
Table 6 Global Voice Mood Disorder Dx Market Outlook, By Cloud (2024-2032) ($MN)
Table 7 Global Voice Mood Disorder Dx Market Outlook, By On-premise (2024-2032) ($MN)
Table 8 Global Voice Mood Disorder Dx Market Outlook, By Disorder Type (2024-2032) ($MN)
Table 9 Global Voice Mood Disorder Dx Market Outlook, By Depression (2024-2032) ($MN)
Table 10 Global Voice Mood Disorder Dx Market Outlook, By Bipolar Disorder (2024-2032) ($MN)
Table 11 Global Voice Mood Disorder Dx Market Outlook, By Anxiety Disorders (2024-2032) ($MN)
Table 12 Global Voice Mood Disorder Dx Market Outlook, By Post-Traumatic Stress Disorder (PTSD) (2024-2032) ($MN)
Table 13 Global Voice Mood Disorder Dx Market Outlook, By Schizophrenia (2024-2032) ($MN)
Table 14 Global Voice Mood Disorder Dx Market Outlook, By Other Disorder Types (2024-2032) ($MN)
Table 15 Global Voice Mood Disorder Dx Market Outlook, By Biomarker Type (2024-2032) ($MN)
Table 16 Global Voice Mood Disorder Dx Market Outlook, By Frequency-based Biomarkers (2024-2032) ($MN)
Table 17 Global Voice Mood Disorder Dx Market Outlook, By Amplitude-based Biomarkers (2024-2032) ($MN)
Table 18 Global Voice Mood Disorder Dx Market Outlook, By Vocal Fold Dynamics-based Biomarkers (2024-2032) ($MN)
Table 19 Global Voice Mood Disorder Dx Market Outlook, By Other Biomarker Types (2024-2032) ($MN)
Table 20 Global Voice Mood Disorder Dx Market Outlook, By Technology (2024-2032) ($MN)
Table 21 Global Voice Mood Disorder Dx Market Outlook, By Voice Biomarkers (2024-2032) ($MN)
Table 22 Global Voice Mood Disorder Dx Market Outlook, By Natural Language Processing (NLP) (2024-2032) ($MN)
Table 23 Global Voice Mood Disorder Dx Market Outlook, By Machine Learning Algorithms (2024-2032) ($MN)
Table 24 Global Voice Mood Disorder Dx Market Outlook, By Acoustic Signal Processing (2024-2032) ($MN)
Table 25 Global Voice Mood Disorder Dx Market Outlook, By Application (2024-2032) ($MN)
Table 26 Global Voice Mood Disorder Dx Market Outlook, By Cognitive (2024-2032) ($MN)
Table 27 Global Voice Mood Disorder Dx Market Outlook, By Behavioral (2024-2032) ($MN)
Table 28 Global Voice Mood Disorder Dx Market Outlook, By End User (2024-2032) ($MN)
Table 29 Global Voice Mood Disorder Dx Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
Table 30 Global Voice Mood Disorder Dx Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
Table 31 Global Voice Mood Disorder Dx Market Outlook, By Telehealth Providers (2024-2032) ($MN)
Table 32 Global Voice Mood Disorder Dx Market Outlook, By Research Institutions (2024-2032) ($MN)
Table 33 Global Voice Mood Disorder Dx Market Outlook, By Mental Health Apps & Platforms (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.